Search

In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a discussion on emerging industry developments and common issues that cannabis businesses face today. This month's program featured content covering current regulatory landscape and how it impacts your business. Interested in...

Please join Saul Ewing LLP and ARIAS U.S. for a half-day educational workshop and networking opportunity. For event inquiries, please contact info@arias-us.org. Panel Discussions Primer on Mass Tort Bankruptcies and Insolvencies The Current Lay of the Land, Including Scottish Re, Arrowood Crossroads...

Saul Ewing attorneys hosted a timely discussion on topics relating to Minnesota’s new adult-use cannabis law. During this one-hour program, we examined the implications of the law for all Minnesota employers, including those relating to drug testing and drug-free workplace policies. We also...

January 26, 2024 - With AI poised to reshape the practice of law and businesses in every industry, Saul Ewing is pleased to partner with the ABA’s Intellectual Property Litigation Committee in forming the AI Subcommittee. The AI Subcommittee will monitor legal and technological developments in this...

Cynthia Gomez will be a Panelist at the October 18th CLE Luncheon Hosted by the American Immigration Lawyers Association in Miami, FL. Cynthia will be one of four panelists, along with leaders from the Customs and Border Patrol offices in South Florida. The topic for Cynthia's panel is Department of...

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...